Stay updated on JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial page.

Latest updates to the JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.3.3 to the Record History and removed HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision entry v3.3.2 was added to the Record History, replacing v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check35 days agoChange DetectedAdded Revision: v3.3.1 and removed Revision: v3.2.0 from the record history. This update concerns versioning metadata of the page and does not alter study details, status, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe government funding notice at the top of the page was removed.SummaryDifference0.8%

- Check57 days agoChange DetectedRecord History shows updates to core trial details across versions, including Recruitment Status, Study Status, Study Design, and Eligibility. The latest version includes changes to Outcomes and Contacts/Locations as well.SummaryDifference0.1%

- Check85 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference13%

Stay in the know with updates to JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial page.